Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The University of Nebraska Medical Center and the Omaha VA hospital are taking part in a nationwide study to find new treatment options for patients with type II diabetes.
The $2.1 million, five-year study will enroll 5,000 type II diabetes patients who take only the drug Metformin to control their diabetes. The purpose of the study is find out what other drugs can be used in combination with Metformin to treat the disease.
“Most diabetics fail the first drug after two to four years,” said Dr. Cyrus Desouza, principal investigator of the study. “We don’t know the second best drug to use after Metformin.”
Patients will continue taking Metformin, which is used to decrease glucose levels and increase the body’s response to insulin, in addition to one of four randomly selected drugs.
http://www.kvnonews.com/2013/07/diabetes-study-aims-for-better-treatment-options/
Surely the 'second best drug' will depend on the individual, given the diversity of presentations of diabetes?
The $2.1 million, five-year study will enroll 5,000 type II diabetes patients who take only the drug Metformin to control their diabetes. The purpose of the study is find out what other drugs can be used in combination with Metformin to treat the disease.
“Most diabetics fail the first drug after two to four years,” said Dr. Cyrus Desouza, principal investigator of the study. “We don’t know the second best drug to use after Metformin.”
Patients will continue taking Metformin, which is used to decrease glucose levels and increase the body’s response to insulin, in addition to one of four randomly selected drugs.
http://www.kvnonews.com/2013/07/diabetes-study-aims-for-better-treatment-options/
Surely the 'second best drug' will depend on the individual, given the diversity of presentations of diabetes?